327 related articles for article (PubMed ID: 27983491)
1. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
Baxter M; Morgan M
Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
3. A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis.
Nei T; Akutsu K; Shima A; Tsuboi I; Suzuki H; Yamamoto T; Tanaka K; Shinoyama A; Kojima Y; Washio Y; Okawa S; Sonobe K; Norose Y; Saito R
J Infect Chemother; 2012 Dec; 18(6):919-24. PubMed ID: 22327489
[TBL] [Abstract][Full Text] [Related]
4. Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.
Yoshizawa S; Matsumura T; Ikebe T; Ichibayashi R; Fukui Y; Satoh T; Tsubota T; Honda M; Ishii Y; Tateda K; Ato M
J Infect Chemother; 2019 May; 25(5):355-361. PubMed ID: 30744988
[TBL] [Abstract][Full Text] [Related]
5. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.
Norrby-Teglund A; Muller MP; Mcgeer A; Gan BS; Guru V; Bohnen J; Thulin P; Low DE
Scand J Infect Dis; 2005; 37(3):166-72. PubMed ID: 15849047
[TBL] [Abstract][Full Text] [Related]
6. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
[TBL] [Abstract][Full Text] [Related]
7. Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited.
Sendi P; El Hay MA; Brandt CM; Spellerberg B
Emerg Infect Dis; 2017 Jan; 23(1):150-152. PubMed ID: 27983484
[TBL] [Abstract][Full Text] [Related]
8. Toxic shock syndrome and streptococcal myositis: three case reports.
Watkins R; Vyas H
Eur J Pediatr; 2002 Sep; 161(9):497-8. PubMed ID: 12200610
[TBL] [Abstract][Full Text] [Related]
9. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.
Kaul R; McGeer A; Norrby-Teglund A; Kotb M; Schwartz B; O'Rourke K; Talbot J; Low DE
Clin Infect Dis; 1999 Apr; 28(4):800-7. PubMed ID: 10825042
[TBL] [Abstract][Full Text] [Related]
12. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
Feigenberg T; Sela HY; Applbaum YH; Mankuta D
Isr Med Assoc J; 2008 Jun; 10(6):483-4. PubMed ID: 18669156
[No Abstract] [Full Text] [Related]
13. [Toxic shock-like syndrome caused by streptococci].
van Dissel JT; Kullberg BJ; van der Meer JW
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal toxic shock syndrome - a life-threatening condition caused by various streptococcal species.
Bartoš H; Fabianová L; Dlouhý P
Epidemiol Mikrobiol Imunol; 2018; 67(2):82-86. PubMed ID: 30126285
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiae subspecies equisimilis in breast cancer-related lymphedema: a case report.
Sumazaki M; Saito F; Ogata H; Yoshida M; Kubota Y; Magoshi S; Kaneko H
J Med Case Rep; 2017 Jul; 11(1):191. PubMed ID: 28705211
[TBL] [Abstract][Full Text] [Related]
16. An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C.
Cone LA; Stone RA; Schlievert PM; Sneider RA; Rubin AM; Jesser K; Renker SW
Scand J Infect Dis; 2006; 38(11-12):960-3. PubMed ID: 17148061
[TBL] [Abstract][Full Text] [Related]
17. Infections due to group A streptococcus: new concepts and potential treatment strategies.
Norrby SR; Norrby-Teglund A
Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
[TBL] [Abstract][Full Text] [Related]
18. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection.
Shah PJ; Vakil N; Kabakov A
Am J Health Syst Pharm; 2015 Jun; 72(12):1013-9. PubMed ID: 26025992
[TBL] [Abstract][Full Text] [Related]
19. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for toxic shock syndrome.
Barry W; Hudgins L; Donta ST; Pesanti EL
JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
